Amgen's stock price rises 3% due to the success of its autoimmune disease drug in late-stage trials
2026-09-22 21:40:07
According to CoinMeta, as reported by Reuters, Amgen's ($GBG) stock price rose by 3% due to the success of its autoimmune disease drugs in late-stage trials.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.